The use of B-type natriuretic peptides in the intensive care unit

Critical Care Medicine

Volumn 35, Issue 10, 2007, Pages 2438-2439

  Mueller, Christian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Diagnosis; Management; Natriuretic peptides; Prognosis; Respiratory failure

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

CARDIOGENIC SHOCK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL DECISION MAKING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; DISEASE MARKER; ECHOCARDIOGRAPHY; EDITORIAL; EMERGENCY WARD; HEART CATHETERIZATION; HEART DISEASE; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FAILURE; HEART STRESS; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY FAILURE; SEPSIS; SEPTIC SHOCK; TRICUSPID VALVE DISEASE;

CRITICAL ILLNESS; HEART DISEASES; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS;

EID: 34748907254     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000284490.11110.2E     Document Type: Editorial

References (13)

1. Mueller C, Breidthardt T, Laule-Kilian K, et al: The integration of BNP and NT-proBNP into clinical medicine. Swiss Med Wkly 2007; 137:4-12
2. Iwanaga Y, Nishi I, Furuichi S, et al: B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure. J Am Coll Cardiol 2006; 47:742-748
3. Mueller C, Scholer A, Laule-Kilian K, et al: Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004; 350:647-654
4. McLean AS, Tang B, Nalos M, et al: Increased B-type natriuretic peptide (BNP) level is a strong predictor for cardiac dysfunction in intensive care unit patients. Anaesth Intensive Care 2003; 31:21-27
5. Karmpaliotis D, Kirtane AJ, Ruisi CP, et al: Diagnostic and prognostic utility of brain natriuretic peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema. Chest 2007; 131:964-971
6. Abroug F, Ouanes-Besbes L, Nciri N, et al: Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: Diagnostic performance of biomarkers. Am J Respir Crit Care Med 2006; 174:990-996
7. Charpentier J, Luyt CE, Fulla Y, et al: Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 2004; 32:660-665
8. McLean AS, Huang SJ, Hyams S, et al: Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock. Crit Care Med 2007; 35:1019-1026
9. Meyer B, Huelsmann M, Wexberg P, et al: N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients. Crit Care Med 2007; 35:2268-2273
10. Tung RH, Garcia C, Morss AM, et al: Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med 2004; 32:1643-1647
11. Forfia PR, Watkins SP, Rame JE, et al: Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit. J Am Coll Cardiol 2005; 45:1667-1671
12. Mekontso-Dessap A, de Prost N, Girou E, et al: B-type natriuretic peptide and weaning from mechanical ventilation. Intensive Care Med 2006; 32:1529-1536
13. Grasso S, Leone A, De Michele M, et al: Use of N-terminal pro-brain natriuretic peptide to detect acute cardiac dysfunction during weaning failure in difficult-to-wean patients with chronic obstructive pulmonary disease. Crit Care Med 2007; 35:96-105